Latest Breaking News On - Exchange warrant - Page 5 : comparemela.com

Aytu BioPharma, Inc : Aytu BioPharma Announces Pricing of $4 0 Million Public Offering Priced At-The-Market and the Appointment of a New Director

Abhinav Jain of Nantahala Capital Management, LLC Joins the Company's Board of Directors Upon ClosingPotential for Additional $7 Million in Event of Exercise of Common Warrants in FullExtends Interest

New yorkUnited statesAytu biopharmaMark okiJosh disbrowAbhinav jainAbhinav abi jainRoger weissAbi jainMassachusetts institute of technologyExchange commissionGordon coAytu biopharma incAytu biopharma inc viewVenture opportunities fundConsumer health

Aytu BioScience (AYTU) Prices $4M Share Offering

Aytu BioScience (AYTU) Prices $4M Share Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesAbhinav jainMark okiAbhinav abi jainAbi jainRoger weissAytu biopharmaJosh disbrowConsumer health segmentVenture opportunities fundWharton school of the university pennsylvaniaGordon coAytu biopharma incNantahala capital managementMaxim group

Aytu BioPharma Announces Pricing of $4 0 Million Public Offering Priced At-The-Market and the Appointment of a New Director

Aytu BioPharma Announces Pricing of $4 0 Million Public Offering Priced At-The-Market and the Appointment of a New Director
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesAbhinav abi jainRoger weissAbi jainAytu biopharmaMark okiJosh disbrowAbhinav jainAytu biopharma incVenture opportunities fundConsumer healthExchange commissionGordon coMassachusetts institute of technologyConsumer health segment

Aytu BioPharma Announces Pricing of $4 0 Million Public Offering Priced

Aytu BioPharma Announces Pricing of $4 0 Million Public Offering Priced
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesJosh disbrowAbi jainAbhinav jainAbhinav abi jainNews networkConsumer health segmentNantahala capital managementConsumer healthGordon coCompany board of directorsWharton school of the university pennsylvaniaAytu biopharma incVenture opportunities fundMassachusetts institute of technology

AVALO THERAPEUTICS, INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)

Item 1.01. Entry into a Material Definitive Agreement. On May 31, 2023, Avalo Therapeutics, Inc. entered into an exchange agreement with entities affiliated with Venrock Healthcare Capital. | June 2, 2023

United statesAvalo therapeutics incExchange agreementMaterial definitiveHealthcare capital partnersExchanging stockholdersExchange warrantsCommon stockExchange warrantCurrent reportSecurities actEdgar onlineAvalo therapeuticsNc stock exchangePress releaseEalthcare avtx us05338f2074